Antithrombotic therapy
The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy
... no antithrombotic therapy, those taking warfarin had lower rates of fall-related hemorrhagic ...warfarin therapy, choosing only those who are sufficiently healthy to be at much lower than average ...
6
The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
... of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European ...
5
Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence
... Purpose: For years, older patients have been prescribed multiple blood-thinning medications (complex antithrombotic therapy [CAT]) to decrease their risk of cardiovascular events. These ther- apies, ...
12
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy
... botic therapy has been shown to be ineffective in preventing PE in women with ...that antithrombotic therapy is unsuccessful in preventing placental insufficiency and associated maternal and fetal ...
9
Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
... mendations exist to aid in the prevention of bleeding events. Principally, risk stratification using GRACE and CRUSADE risk scores can help to identify high-risk patient populations. Once these populations are ...
15
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
... Khurram et al. [11] evaluated 107 patients who were treated up to 12 months with TT following PCI-S (drug- eluting stents in 50% of cases). A contemporary cohort of an additional 107 patients with no indication for OAC ...
11
Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
... Introduction: Therapeutically induced androgen deficiency (AD) is a standard treatment for patients with prostate cancer, but it is often associated with various adverse effects (AEs) that may lead to discontinuation. ...
8
Antithrombotic therapy after mitral valve repair: VKA or aspirin?
... optimal antithrombotic therapy following mitral valve repair (MVr) is still a matter of ...two antithrombotic prevention strategies: vitamin K antagonists (VKA) versus ...aspirin therapy ...
9
Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
... The mean antithrombotic therapy duration was 15.2 ± 6 years (range 0.7–32 years). Although the tar- get INR (international normalized ratio) was 2.0 (range 1.6–2.5; AHA/ASA, 2006), INR values between 1.5 ...
6
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group
... Subjects with the rare autosomal dominant disease Hereditary Hemorrhagic Telangiectasia (HHT) may develop medical conditions that require antithrombotic therapy (AT). However, safety of AT is uncertain in ...
5
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection
... on antithrombotic therapy and ...on antithrombotic therapy, with no significant difference between the ...on antithrombotic therapy were also taking an antiplatelet agent, with 5 ...
8
Antithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy
... current antithrombotic therapy At present, there is agreement that vessel wall inflamma- tion is a major factor in the development of atherosclero- sis, atheroma instability, and plaque disruption, events ...
9
Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
... Limitations of this study were as follows: 1) it is a single medical center survey, 2) the sample size was relatively small, and 3) the quality of OAT use was not studied. Patients on OAT might not get therapeutic level ...
5
Antithrombotic therapy in patients with atrial fibrillation : the Tasmanian experience
... of antithrombotic agent(s) in patients with multiple comorbidities, and the monitoring of ...of antithrombotic medications, including the DOACs, in the treatment of AF and a comprehensive national guideline ...
200
Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP/START criteria: a cross-sectional study
... of antithrombotic drugs in elderly patients, particularly in developing countries such as Ethiopia as it is the first study in this ...of antithrombotic therapy as the study design is a retrospective ...
9
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
... All the patients who underwent randomization were to be followed through 6 months, with an additional visit at month 7 to record transitions in antithrombotic therapy and associated out- comes. The primary ...
17
Triple antithrombotic therapy for atrial fibrillation and coronary stents
... of antithrombotic therapy in atrial fibrillation patients present- ing with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European ...
7
Does antithrombotic therapy improve survival with colorectal cancer?
... platelet therapy may result in an increased incidence of solid cancers ...antiplatelet therapy may inhibit tumor ...between antithrombotic therapy (ATT) and prognosis in patients with ...
8
MOLECULAR MODELLING, 3D QSAR, AND DRUG DOCKING STUDIES ON THE ROLE OF NATURAL ANTICOAGULANT COMPOUNDS IN ANTITHROMBOTIC THERAPY
... halting therapy, nausea, vomiting, hives, and breathing trouble 14 .... Antithrombotic drugs function in two ways: as anticoagulants that decrease fibrin formation and as antiplatelets that inhibit clot ...
12
Antithrombotic Therapy in Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Network Meta-Analysis
... different antithrombotic therapies in the prevention of SVGF to provide evidence-based guidance for optimal prophylactic ...dual-antiplatelet therapy with aspirin and clopidogrel, a second-best treatment, ...
157